Inventor · disambiguated record
Juniper A. Scribner
Also filed as: SCRIBNER JUNIPER A
3 granted patents·8 pending applications·3 citations·filing 2017–2024
58Inventor score
Top patents by PatentIndex Score
11 records- 0183US11242402B2ADAM9-binding molecules, and methods of use thereofMACROGENICS INC·Filed 2017·Granted Feb 8, 2022·2 cites·38 claims
- 0280US2025115676A1ADAM9-Binding Molecules, and Methods of Use ThereofMACROGENICS INC·Filed 2024·Application pending·0 cites
- 0378US10961311B2B7-H3 binding molecules, antibody drug conjugates thereof and methods of use thereofMACROGENICS INC·Filed 2017·Granted Mar 30, 2021·1 cites·39 claims
- 0473US2023272084A1B7-h3 directed antibody drug conjugatesMACROGENICS INC·Filed 2023·Application pending·0 cites
- 0570US2022324995A1ADAM9-Binding Molecules, and Methods of Use ThereofMACROGENICS INC·Filed 2021·Application pending·0 cites
- 0668US11591400B2B7-H3 directed antibody drug conjugatesMACROGENICS INC·Filed 2020·Granted Feb 28, 2023·0 cites·27 claims
- 0757US2025135022A1Methods for the use of a b7-h3 antibody-drug conjugate in combination with a pd-1 x ctla-4 bispecific moleculeMACROGENICS INC·Filed 2023·Application pending·0 cites
- 0854US2023226206A1Methods for the use of a b7-h3 antibody-drug conjugate alone or in combinationMACROGENICS INC·Filed 2021·Application pending·0 cites
- 0951US2024165256A1Methods for increasing efficacy of immunoconjugates targeting adam9 for the treatment of cancerIMMUNOGEN INC·Filed 2022·Application pending·0 cites
- 1050US2021275685A1Immunoconjugates targeting adam9 and methods of use thereofIMMUNOGEN INC·Filed 2019·Application pending·0 cites
- 1144US2021388102A1Immunoconjugates targeting adam9 and methods of use thereofIMMUNOGEN INC·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →